Enteral Access Technologies
1 known investors
Find your way into Enteral Access Technologies
Sign up to see every warm intro you have to Enteral Access Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Enteral Access Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Enteral Access Technologies develops medical devices for safe placement of nasogastric feeding and decompression tubes in clinical settings. The company manufactures DoubleCHEK™, a combined CO2 and pH indicator device that reduces misplacement risk and unnecessary radiation exposure.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Enteral Access Technologies do?
- Enteral Access Technologies develops medical devices for safe placement of nasogastric feeding and decompression tubes in clinical settings. The company manufactures DoubleCHEK™, a combined CO2 and pH indicator device that reduces misplacement risk and unnecessary radiation exposure.
- Who founded Enteral Access Technologies?
- Enteral Access Technologies was founded by George Gallagher.
- Who are Enteral Access Technologies's investors?
- Enteral Access Technologies's investors include British Design Fund.
